HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R Bolli Selected Research

N 0861

9/2001Protection of IB-MECA against myocardial stunning in conscious rabbits is not mediated by the A1 adenosine receptor.
3/2001A(1) or A(3) adenosine receptors induce late preconditioning against infarction in conscious rabbits by different mechanisms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


R Bolli Research Topics

Disease

7Infarction (Infarctions)
12/2005 - 11/2000
6Myocardial Infarction
04/2014 - 08/2000
6Ischemia
11/2001 - 11/2000
5Coronary Occlusion
07/2001 - 08/2000
3Myocardial Ischemia (Ischemic Heart Diseases)
07/2014 - 04/2001
3Cardiomegaly (Heart Hypertrophy)
12/2001 - 06/2000
3Reperfusion Injury
11/2001 - 04/2001
3Myocardial Stunning (Stunned Myocardium)
09/2001 - 08/2000
2Heart Diseases (Heart Disease)
05/2009 - 09/2001
2Hypertrophy
12/2001 - 09/2001
2Heart Failure
12/2001 - 01/2001
1Cicatrix (Scar)
12/2013
1Cardiomyopathies (Cardiomyopathy)
12/2005
1Acute Coronary Syndrome
01/2001
1Hypoxia (Hypoxemia)
01/2001
1Septic Shock (Toxic Shock Syndrome)
01/2001
1Headache (Headaches)
07/2000

Drug/Important Bio-Agent (IBA)

4Protein Kinase CIBA
12/2001 - 06/2000
3N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA
09/2001 - 03/2001
3Purinergic P1 Receptors (Adenosine Receptor)IBA
09/2001 - 03/2001
3N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA
08/2001 - 08/2000
3Nitric Oxide Synthase (NO Synthase)IBA
07/2001 - 11/2000
2Protein Kinase C-epsilonIBA
12/2001 - 06/2000
2Protein Isoforms (Isoforms)IBA
12/2001 - 06/2000
2Adenosine (Adenocard)FDA LinkGeneric
11/2001 - 08/2001
2Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2001 - 11/2000
2EnzymesIBA
11/2001 - 08/2000
2N 0861IBA
09/2001 - 03/2001
2Tyrosine (L-Tyrosine)FDA Link
07/2001 - 11/2000
2Proteins (Proteins, Gene)FDA Link
07/2001 - 08/2000
2Phosphotransferases (Kinase)IBA
07/2001 - 11/2000
25-hydroxydecanoic acidIBA
03/2001 - 11/2000
2Nitroarginine (NG Nitro L Arginine)IBA
03/2001 - 11/2000
2Adenosine Triphosphate (ATP)IBA
03/2001 - 11/2000
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
04/2014
1Receptors for Activated C KinaseIBA
12/2001
1Protein Kinase C betaIBA
12/2001
1NexusIBA
12/2001
1EndotoxinsIBA
11/2001
1Opioid Analgesics (Opioids)IBA
11/2001
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
11/2001
1Biological ProductsIBA
11/2001
1Peptides (Polypeptides)IBA
09/2001
1IsoenzymesIBA
09/2001
1NitratesIBA
08/2001
1Nitroglycerin (Dynamite)FDA LinkGeneric
08/2001
1Adenosine A1 ReceptorIBA
08/2001
1Adenosine A3 ReceptorIBA
08/2001
1alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA
07/2001
1PhosphotyrosineIBA
07/2001
1AntibodiesIBA
07/2001
1Superoxide DismutaseIBA
04/2001
1Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
04/2001
12- (4- (2- carboxyethyl)phenethylamino)- 5'- N- ethylcarboxamidoadenosineIBA
03/2001
1PotassiumIBA
03/2001
1I-kappa B Proteins (I kappa B)IBA
01/2001
1LipopolysaccharidesIBA
01/2001
1Free RadicalsIBA
01/2001
1CytokinesIBA
01/2001
1NF-kappa B (NF-kB)IBA
01/2001
1Nitric Oxide DonorsIBA
11/2000
1Oxidants (Oxidizing Agents)IBA
11/2000
1triphenyltetrazoliumIBA
11/2000
1lavendustin AIBA
11/2000
1Glycine (Aminoacetic Acid)FDA LinkGeneric
11/2000
1Tyrosine Kinase InhibitorsIBA
11/2000
1S-Nitroso-N-AcetylpenicillamineIBA
11/2000
1Diazoxide (Hyperstat)FDA Link
11/2000
1CalciumIBA
11/2000
1chelerythrineIBA
11/2000
1AntioxidantsIBA
11/2000
1Messenger RNA (mRNA)IBA
08/2000
1ProstaglandinsIBA
08/2000
1Ribonucleases (Ribonuclease)IBA
08/2000
1Celecoxib (Celebrex)FDA Link
08/2000
1Intravenous Immunoglobulins (IVIG)FDA Link
07/2000
1Ventricular MyosinsIBA
06/2000

Therapy/Procedure

3Therapeutics
07/2014 - 12/2013
2Cell- and Tissue-Based Therapy (Cell Therapy)
05/2009 - 12/2005